RNU1-142P

Across TCGA pan-cancer cohorts, RNU1-142P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU1-142P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RNU1-142P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU1-142P expression acts as an unfavorable survival marker, although some lineages such as SKCM show a favorable association.

KIRC, BLCA, and LAML are the cancer types where RNU1-142P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.422	0.808	<.001	168	view →
BLCA	DFS	Tertile	All	0.196	0.627	.009	54	view →
LAML	DFS	Tertile	All	0.028	0.572	<.001	36	view →
HNSC	OS	Tertile	All	0.167	0.751	<.001	36	view →
ESCA	DFS	Tertile	All	0.416	0.507	<.001	24	view →
STAD	OS	Tertile	All	0.494	0.695	.033	18	view →
LUAD	DFS	Tertile	IV	0.342	0.893	<.001	18	view →
SKCM	OS	Tertile	All	1.000	0.300	.018	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU1-142P–KIRC (OS)

Open the KIRC breakdown →